Agreed, and Bas has pointed out the mixed messaging. Our chairman says commercialization we'll be determined by the end of the fiscal year, we'll stick with that until new info becomes available. An update on the 2024 CBM program should keep shareholders informed on that front given we know Grandis is currently the main focus.
General chit chat thread., page-2971
Add EXR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $119.0M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 10.5¢ | 10.0¢ | $27.56K | 265.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 33 | 2114856 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 218014 | 10 |
View Market Depth
| Last trade - 11.01am 17/06/2024 (20 minute delay) ? |
|
|||||
|
Last
10.3¢ |
Change
0.000 ( 0.19 %) |
||||
| Open | High | Low | Volume | ||
| 10.3¢ | 10.3¢ | 10.3¢ | 100000 | ||
| Last updated 11.32am 17/06/2024 ? | |||||
| EXR (ASX) Chart |
